Duker Jay S. (CIK 1630864) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-24). Recent activity: Sell EYPT (76,766 shares), Buy EYPT (76,766 shares), Buy EYPT (1,500 shares), Buy EYPT (20,793 shares), Sell EYPT (10,054 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-24 | EyePoint, Inc. (EYPT) | President and CEO | Sell | 76,766 | $1.0M |
| 2026-03-24 | EyePoint, Inc. (EYPT) | President and CEO | Buy | 76,766 | $1.0M |
| 2026-03-16 | EyePoint, Inc. (EYPT) | President and CEO | Buy | 1,500 | $19,725 |
| 2026-01-07 | EyePoint, Inc. (EYPT) | President and CEO | Buy | 20,793 | $0 |
| 2026-01-07 | EyePoint, Inc. (EYPT) | President and CEO | Sell | 10,054 | $169,510 |
| 2026-01-06 | EyePoint, Inc. (EYPT) | President and CEO | Buy | 65,000 | $0 |
| 2026-01-06 | EyePoint, Inc. (EYPT) | President and CEO | Sell | 23,447 | $409,854 |
| 2026-01-06 | EyePoint, Inc. (EYPT) | President and CEO | Buy | 30,000 | $0 |
| 2026-01-06 | EyePoint, Inc. (EYPT) | President and CEO | Sell | 14,505 | $252,822 |
| 2025-07-11 | EyePoint Pharmaceuticals, Inc. (EYPT) | President and CEO | Buy | 16,667 | $0 |
| 2025-07-11 | EyePoint Pharmaceuticals, Inc. (EYPT) | President and CEO | Sell | 7,688 | $85,029 |
| 2025-06-25 | EyePoint Pharmaceuticals, Inc. (EYPT) | President and CEO | Sell | 56,665 | $465,220 |
| 2025-03-20 | EyePoint Pharmaceuticals, Inc. (EYPT) | President and CEO | Sell | 20,000 | $123,200 |
| 2025-02-11 | EyePoint Pharmaceuticals, Inc. (EYPT) | President and CEO | Buy | 7,000 | $0 |
| 2025-02-11 | EyePoint Pharmaceuticals, Inc. (EYPT) | President and CEO | Sell | 2,055 | $13,358 |
Source: SEC Form 4 filings · as of 2026-03-24